Thermo Fisher announced that its board of directors has authorized the repurchase of $4B of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. This replaces the company’s existing repurchase authorization, of which $1B was remaining.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TMO:
- 5 Top Value Stocks to Buy Now, According to Analysts – November 2023
- Novo hires Fujifilm unit to fill Wegovy injection pens, Reuters reports
- Repligen price target lowered to $210 from $240 at KeyBanc
- Microsoft upgraded, F5 Networks downgraded: Wall Street’s top analyst calls
- Thermo Fisher price target lowered to $545 from $590 at Deutsche Bank